Keywords: boehringer, tipranavir, shows, early, promise, hiv, ingelheim

Boehringer's tipranavir shows early promise in HIV

Article | 15 March 2001

Print This

Boehringer Ingelheim's tipranavir, the first in a new class ofnon-peptidic HIV protease inhibitors, has shown promising results in a number ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in